Lichen planus-type chronic graft-versus-host disease complicated by mucous membrane pemphigoid with positive anti-BP180/230 and scleroderma-related autoantibodies followed by reduced regulatory T cell frequency.
Takaaki
T
Hanafusa
Hiroaki
H
Azukizawa
Megumi
M
Nishioka
Atsushi
A
Tanemura
Hiroyuki
H
Murota
Hisao
H
Yoshida
Emiko
E
Sato
Yoshiko
Y
Hashii
Keiichi
K
Ozono
Hiroshi
H
Koga
Takashi
T
Hashimoto
Ichiro
I
Katayama
D000293:Adolescent; D001323:Autoantibodies / Q000097:blood*; D001324:Autoantigens / Q000276:immunology; D002352:Carrier Proteins; D002908:Chronic Disease; D003598:Cytoskeletal Proteins; D000071821:Dystonin; D006086:Graft vs Host Disease / Q000150:complications / Q000188:drug therapy / Q000276:immunology*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008010:Lichen Planus / Q000150:complications / Q000473:pathology; D018655:Lymphocyte Count; D008297:Male; D008562:Membrane Glycoproteins / Q000276:immunology; D009061:Mouth Mucosa / Q000473:pathology; D009419:Nerve Tissue Proteins; D024041:Non-Fibrillar Collagens / Q000276:immunology; D010391:Pemphigoid, Bullous / Q000150:complications / Q000188:drug therapy / Q000276:immunology*; D036102:Peripheral Blood Stem Cell Transplantation / Q000009:adverse effects; D050378:T-Lymphocytes, Regulatory; D016559:Tacrolimus / Q000627:therapeutic use; D000097805:Collagen Type XVII
D001323:Autoantibodies; D001324:Autoantigens; D002352:Carrier Proteins; D003598:Cytoskeletal Proteins; D000071821:Dystonin; D007166:Immunosuppressive Agents; D008562:Membrane Glycoproteins; D009419:Nerve Tissue Proteins; D024041:Non-Fibrillar Collagens; D016559:Tacrolimus; D000097805:Collagen Type XVII; C486268:DST protein, human